Zafgen Inc said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical hold on the investigational new drug application for a trial of its experimental diabetes drug.
FDA puts Zafgen's diabetes trial on hold
Reviewed by jenisht
on
November 26, 2018
Rating: 5
No comments: